BDR Pharma Unveils Innovative Oral Solution for Prostate Cancer in India
In India, BDR Pharmaceuticals has introduced BDENZA, an oral solution containing 32 mg/mL for the treatment of prostate cancer.
Menu
In India, BDR Pharmaceuticals has introduced BDENZA, an oral solution containing 32 mg/mL for the treatment of prostate cancer.
Significant investments were seen in 2023 in healthcare technology, including telehealth, virtual treatments, obesity treatments, MedTech, and medical advancements.
Dr. S R Narahari, a physician from Kerala, creates history when his innovative integrative medicine for lymphatic filariasis and
A notice about incomplete eligibility certificate applications from MBBS students who studied overseas without the necessary paperwork has been
In its pre-budget recommendations, AiMeD impels the government to address the high import bill, which exceeds Rs 63,200 crore.
The National Medical Commission (NMC) has issued a recent notification introducing the “Post-Graduate Medical Education Regulations, 2023.” The mandate
Copyright © 2025 Medipreneur. All rights reserved.
